Cargando…

Durability of the humoral immune response in recovered COVID-19 patients

BACKGROUND: The immunological factors involved in protection against the disease caused by SARS-CoV-2 are insufficiently defined and understood. However, previous knowledge pertaining to the related SARS virus and other human coronaviruses may prove useful. Population-based serosurveys measuring ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahallawi, Waleed, Alzahrani, Mohammad, Alahmadey, Ziab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884256/ https://www.ncbi.nlm.nih.gov/pubmed/33613046 http://dx.doi.org/10.1016/j.sjbs.2021.02.011

Ejemplares similares

Prolonged humoral and cellular immunity in COVID-19-recovered patients()
por: Alsayb, May A., et al.
Publicado: (2021)

Humoral immune responses in hospitalized COVID-19 patients
por: Mahallawi, Waleed H.
Publicado: (2021)

Liver and Renal Impairments in COVID-19 Patients of Madinah City of Saudi Arabia: A Cross-Sectional Study (2020)
por: Mohammedsaeed, Walaa, et al.
Publicado: (2023)

Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Case Report: A Recovered SARS CoV-2 Patient Protected From Reinfection
por: Mahallawi, Waleed
Publicado: (2020)

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
por: Bhattacharya, Deepta
Publicado: (2022)

Prognostic factors for predicting severity and mortality in hospitalized COVID‐19 patients
por: Aljohani, Fahad Dakilallah, et al.
Publicado: (2022)

Assessment of the influenza vaccine (VAXIGRIP) in triggering a humoural immune response
por: Mahallawi, Waleed H.
Publicado: (2017)

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
por: Barouch, Dan H., et al.
Publicado: (2021)

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
por: Brockman, Mark A, et al.
Publicado: (2021)

Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah
por: Mahallawi, Waleed
Publicado: (2018)

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
por: Gerhards, Catharina, et al.
Publicado: (2023)

Peculiarities of Humoral Immunity Formation in Medical Institution Employees Recovered from or Vaccinated against COVID-19 in Irkutsk
por: Dubrovina, V. I., et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis
por: Mahallawi, Waleed H, et al.
Publicado: (2021)

The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients
por: Akbarian, Shadi, et al.
Publicado: (2023)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

Differential immune responses in pregnant patients recovered from COVID-19
por: Chen, Ge, et al.
Publicado: (2021)

Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors
por: Sobarzo, Ariel, et al.
Publicado: (2016)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023)

The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses
por: Eldi, Preethi, et al.
Publicado: (2022)

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
por: Mohn, Kristin G.-I., et al.
Publicado: (2022)

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19
por: Huang, Yongsheng, et al.
Publicado: (2021)

Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
por: Hwang, Ji-Young, et al.
Publicado: (2022)

Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study
por: Zamani, Mohammad, et al.
Publicado: (2022)

Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic
por: Mahallawi, Waleed, et al.
Publicado: (2022)

Humoral immune response to COVID-19 infection or vaccination among celiac disease patients
por: Albatayneh, Eman, et al.
Publicado: (2022)

Live attenuated influenza vaccine induces broadly cross-reactive mucosal antibody responses to different influenza strains in tonsils
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates
por: Cobos Jiménez, Viviana, et al.
Publicado: (2019)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
por: Taeschler, Patrick, et al.
Publicado: (2022)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
por: Gilboa, Mayan, et al.
Publicado: (2022)

The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients
por: Smits, Veronique A.J., et al.
Publicado: (2021)

COVID19 vaccine type and humoral immune response in patients receiving dialysis
por: Garcia, Pablo, et al.
Publicado: (2021)

Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19
por: Tian, Xiaodong, et al.
Publicado: (2022)

Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19
por: Schuster, Daniel J., et al.
Publicado: (2022)

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
por: Charilaou, Paris, et al.
Publicado: (2022)

Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients
por: Sasson, Jennifer M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmj41rc0hvngrsm9f8npb2l8ia